ABSTRACT
India is trying to maintain stability in the current circumstances; another immediate threat has developed in the shape of coronavirus disease- associated mucormycosis. Mucormycosis is uncommon but lethal disease, caused by a group of molds known as mucormycetes. If not treated properly, an infection might be fatal. The most ordinary risk factor is diabetes mellitus, followed by hematological malignancies. Patients with postpulmonary tuberculosis and persistent renal diseases are further probable to extend mucormycosis in India. Trauma increases the risk of cutaneous mucormycosis. Despite a rise in illness awareness among treating physicians, disease-related morbidity and mortality remain high, as patients seek medical attention late in the disease process and medication is expensive. Despite the fact that it has been present since the beginning of the pandemic, the cause of this fungal infection remains unknown. In this review we aimed to summarize about mucormycosis and its epidemiology, pathogen, and treatment options in context to COVID-19.
ABSTRACT
Coronaviruses cause animal and human respiratory and bowel infections. They have not been deemed highly pathogenic to humans until the outbreak of severe acute respiratory syndrome (SARS) in 2002 and 2003 in Guangdong province, China. Coronaviruses (CoVs) are large, enveloped, positive-sense, single-stranded RNA viruses that can infect both animals and humans. Coronaviruses didn't just appear recently. They are large family of viruses that have been around for a long time. Formerly, coronaviruses (CoVs) were seen as relatively harmless respiratory pathogens to humans. However, two outbreaks of severe respiratory tract infection, caused by the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) caused high pathogenicity and mortality rates among human populations as a result of zoonotic CoVs crossing the species barrier. Now the recent detection of the 2019 novel coronavirus (COVID-19), added a new member in corona virus family.The novel coronavirus (COVID 19) is one of the member of coronavirus family which infect human. Scientists have divided coronaviruses into four sub- groupings, called alpha, beta, gamma and delta. Seven of these viruses can infect people. The four common coronaviruses are-229E(alpha), NL63(alpha), OC43(beta), HKU1(beta). The three less-common coronaviruses are- MERS-CoV(beta), SARS-CoV(beta), SARS-CoV-2. Our main target is to describe the the structure, Pathogenecity, Transmissibility and Epidemiology of above mentioned subgroups of corona viruses in our review
ABSTRACT
Tuberculosis is a bacterial infectious illness that is spread mostly by communicable droplets from one person to another. Drug-resistant patients and substandard drug authorization Mycobacterium tuberculosis is one of the two major obstacles to tuberculosis (TB) management in endemic areas, such as India and the rest of the world. Precision medicine, also known as customized medicine, is based on the diversity of systems biology and using predictive techniques to assess health risk and build tailored health plans to assist patients in reducing risk, preventing disease, and treating it with precision. Only active pulmonary tuberculosis is contagious. TB continues to be a significant source of illness and mortality in many low- and middle-income nations, and drug-resistant TB is a major problem in many areas. Furthermore, several novel TB diagnostics methods, such as quick molecular testing, have been developed, and there is a demand for simpler point-of-care tests. Personalized medicine ushers in a new age in healthcare. In the subject of Mycobacteriology, personalized medicine may be used in a variety of ways, including prevention, diagnosis, improved therapy, and prognosis. To change an independent proposition in mycobacterial disorders, a genetic inclination and a protein affliction investigation are presented. Patients' results should be turned into accurate diagnostic tests and focused therapy in order for personalized medicine to be used successfully by the healthcare system.
ABSTRACT
Online learning in medical education is a relatively new concept and one which is rapidly expanding. Recently, due to the global widespread of COVID-19 pandemic, e-learning became the mainstreaming mode of teaching all over the world. Thus, it is critical to assess and work upon the potential challenges, drawbacks and barriers of effective implementation of successful e-learning. The general barriers to e- learning are often encountered as institutional or teaching method norms and technological drawbacks and behavior change in both the learner and the instructor is essential for successful implementation of e- learning in medical education. Although online course delivery has probably eliminated certain barriers that exist in face-to-face classrooms, such as geographic location, transportation issues, architectural and physical impediments, and social contexts which lead to inaccessible learning environments. Thus, it is the responsibility of the medical educators and administrators to look into these challenges and incorporate the solutions which can make begin a new era of better teaching-learning mode of education in medical education in the future This review article analyzes the prominent barriers to e-learning and solutions amongst medical educators to the implementation of online learning in medical education.
ABSTRACT
Thyroid cancer is the prevalent endocrine cancers, and its incidence is growing all over the world, according to the World Health Organization. About 5–10 per cent of individuals with differentiated thyroid carcinoma may experience destructive behavior and metastasis, and their disease will be refractory to therapeutic techniques such as radiation therapy for an unknown cause, despite the favorable prognosis. Most aggressive, deadly, and unresponsive type of the cancer is thyroid carcinoma. Regrettably, existing treatments are not specific and are thus considered poor in treating thyroid malignancies. Consequently, mortality in this malignancy despite progress in diagnosis and treatment is a prominent issue in medicine. evidence linking cellular, molecular, and genetic to a diagnostic and therapeutic simplification. With the new idea of personalized therapy for thyroid cancer diagnosis, arranging the treatment, discovering the success of the treatment and assessing the visualization has improved in the last ten years. Personalized medicine treatment for thyroid cancer is supported by these studies. According to the findings of this review, cellular and molecular processes of cancer will lay concrete on the way for the development of narrative biomarkers for personalized medicine that take individual variations into account
ABSTRACT
Background: Diabetes is one of the commonest and serious metabolic disorders. Much of the morbidity and mortality associated with diabetes is primarily attributed to sequelae requelac of microvascular and macrovascular changes, in which diabetic dyslipidemia is one of the many modifiable risk factors for coronary artery disease, stroke and peripheral vascular disease. Objectives: The main aim of this study was to evaluate the hypoglycemic and antidyslipidemic effect of selected Indian plants in streptozotocin induced diabetic rats. Material and Methods: Azadirachta indica and Ocimm sanctum leaves, Allium sativum bulbs and Momordica charantia fruits were collected, identified taxonomically and extract was obtained. Male Albino rats was used and divided into 8 groups, each consisting of 6 animals, one group act as a control. Diabetes in rats was induced with streptozotocin. Blood samples were collected and biochemical analysis was done for blood sugar, lipid peroxide and lipid profile. The diabetic group without drug treatment was compared with the control, and diabetic plus drug-treated groups were compared with the diabetic group without drug treatment. Data were analyzed using Student ‘t’ test. Results: Our results revealed that administration of streptozotocin in rats caused increase in the levels of glucose, lipid peroxides, cholesterol and triglycerides with lessening of the HDL-cholesterol. Treatment with aqueous extracts of Momordica charantia, Allium sativum, Azadirachta indica and Ocimum sanctum not only reduced the level of blood glucose but also caused lowering of total cholesterol and triglycerides following an increase in the level of HDL-cholesterol. Conclusion: We concluded that the herbal plants tested possess both hypoglycemic and antidyslipidemic activities and their use as a therapeutic tool in diabetes related complications encourage further investigation in this field.